Premium
Management of Chronic Myelocytic Leukemia in Pregnancy by Cell Pheresis
Author(s) -
Caplan S. N.,
Coco F. V.,
Berkman E. M.
Publication year - 1978
Publication title -
transfusion
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.045
H-Index - 132
eISSN - 1537-2995
pISSN - 0041-1132
DOI - 10.1046/j.1537-2995.1978.18178118555.x
Subject(s) - myelocytic leukemia , medicine , platelet , pregnancy , leukemia , immunology , biology , genetics
Cell pheresis was employed in the initial management of a pregnant patient with chronic myelocytic leukemia (CML). Reduction in circulating leukocyte and platelet counts was evident after two weeks of therapy. This technique is an effective mode of management of the pregnant patient with CIVIL and may play an important therapeutic role in the treatment of other myeloproliferative diseases characterized by dangerously high levels of circulating platelets or myeloblasts.